© Heliae Technology Holdings, Inc. 2013 – Confidential 1

Algae: the next frontier in sustainable personal care products

Dr. Lee TonkovichVP of Research & DevelopmentMay 2014

© Heliae Technology Holdings, Inc. 2013 – Confidential

20 acre commercial site2 acre pilot / R&D

NutritionFresh Water

Energy Arable Land

Beverages

Food

Symbioscience

Petcare

Wrigley

Chocolate

Business

Rationale

Heliae – Who are we?Founder’s Rationale

2

Gilbert Arizona130 Associates

Heliae is a technology‐driven algae production company

© Heliae Technology Holdings, Inc. 2013 – Confidential

Algae: untapped opportunity

ANTIOXIDANTS

LIPIDS

3

Algae – versatile organism to convert sunlight into life’s building blocks for billions of years.

Nature utilizes the full value of algae…

Product opportunities are now emerging …PROTEINS

STARCHES

PIGMENTS

© Heliae Technology Holdings, Inc. 2013 – Confidential 4

Algae: Biological Diversity

Nature has provided > 100,000 species*

Genetic modification enables new products

Mutagenesis enhances lipid, pigments, products

Wild alga are found everywhere – soil, water, air

Vast product potential …

* M. Guiry, 2012, How many species of algae are there, J. Phycol, 48, 1057‐1063.

© Heliae Technology Holdings, Inc. 2013 – Confidential

Feed $103 Billion

Cosmetics & Personal Care $127 Billion

Functional Foods & Supplements $183 Billion

Fertilizers $171 Billion

Pharmaceuticals & Therapeutics

$880 Billion

Algae: Market Potential

5

SpecialtyChemicals

$750 Billion

Source: Multiple industry and market sources

© Heliae Technology Holdings, Inc. 2013 – Confidential 6

Heliae Two Year History in Personal Care

• Multiple ingredients: lipids, antioxidants, natural color

• Early stage joint development agreements with multinationals

• Strategic relationships

• Formulation of multiple SKU’s across a broad range of products

• Beauty from within, nutri-cosmetics

• Developing an algae based skin care and ingestible nutri-beauty brand for a 2015 launch

© Heliae Technology Holdings, Inc. 2013 – Confidential

Personal Care Ingredients

Chlorophyll

Phyocyanin

Phycoerythrin

Beta carotene

Astaxanthin

Lutein/Zeaxanthin

Pigments & Carotenoids for personal care –

enhanced by the sun in the Heliae Volaris process

© Heliae Technology Holdings, Inc. 2013 – Confidential

Omega 3 – EPA, DHA, ALAOmega 6Omega 7Omega 9

8

Lipids & Esters enhance personal care topical

and/or ingestible products

Personal Care Ingredients

© Heliae Technology Holdings, Inc. 2013 – Confidential

Ingredients - Astaxanthin

Astaxanthin Oleoresin Powerful natural antioxidant used in supplements for eye, bone/joint, and cardiovascular health

Haematococcus pluvialis

Haematococcus post‐extraction biomass high protein biomass with attractive amino acid profile; applications range from human food, animal feed, personal care in cosmetics

9

© Heliae Technology Holdings, Inc. 2013 – Confidential

Heliae formulating with leaders in Marine-based cosmetics

Heliae ingredients are included in products at prestigious spas

Personal Care Products

10

© Heliae Technology Holdings, Inc. 2013 – Confidential 11

Personal Care Products

• Heliae has made a large array of topical serums, scrubs, masks and lotions from whole algae, algae extracts, and algae based lipids

• We are developing nutri‐cosmetic formulas, combining ingestible and topical applications – including the addition of emerging strains for new ingredients

• Products align with the trend of strong naturalcolors in cosmetics 

© Heliae Technology Holdings, Inc. 2013 – Confidential 12

Identify Strains

Deliver Products

Stage 0: Ideation for market / economics

Stage 1:   Technical feasibility for economics

Stage 2:    Product refinement /optimization

Stage 3:    Pilot scale‐up / product samples

Stage 4:  Pre‐commercial demo to commercial launch

How we work

© Heliae Technology Holdings, Inc. 2013 – Confidential

Stage‐Gate Process

Strain

Feasibility to Optimization

Pilot Scale‐up to Product Samples 

Pre‐commercial Demo to Commercial Launch

How we work

13

© Heliae Technology Holdings, Inc. 2013 – Confidential 14

Delivering Products at Heliae

Development / Pilot facility• Developing new strains and 

products• Derisk scale‐up & commercialization

First commercial production facility (2013)• GMP facility for Haematococcus• Delivering products to the market• Expansion planned

Second commercial facility construction (2015)• Capacity > 1000 tonnes/year• New strain and product line

© Heliae Technology Holdings, Inc. 2013 – Confidential 15

Thank you.

Ltonkovich@heliae.com